Annual EBIT
-$37.49 M
+$10.07 M+21.17%
July 31, 2022
Summary
- As of February 10, 2025, ONCS annual earnings before interest & taxes is -$37.49 million, with the most recent change of +$10.07 million (+21.17%) on July 31, 2022.
- During the last 3 years, ONCS annual EBIT has fallen by -$7.22 million (-23.86%).
Performance
ONCS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBIT
-$6.82 M
+$1.23 M+15.23%
January 31, 2023
Summary
- As of February 10, 2025, ONCS quarterly earnings before interest & taxes is -$6.82 million, with the most recent change of +$1.23 million (+15.23%) on January 31, 2023.
- Over the past year, ONCS quarterly EBIT has increased by +$3.07 million (+31.06%).
Performance
ONCS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBIT
-$32.67 M
+$3.07 M+8.60%
January 31, 2023
Summary
- As of February 10, 2025, ONCS TTM earnings before interest & taxes is -$32.67 million, with the most recent change of +$3.07 million (+8.60%) on January 31, 2023.
- Over the past year, ONCS TTM EBIT has increased by +$10.68 million (+24.64%).
Performance
ONCS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ONCS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.2% | +31.1% | +24.6% |
| 3 y3 years | -23.9% | +49.9% | +13.5% |
| 5 y5 years | -73.4% | +17.6% | +13.5% |
ONCS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.9% | at high | +45.1% | at high | +33.1% |
| 5 y | 5-year | +23.9% | +26.9% | at high | +108.2% | at high | +45.6% |
| alltime | all time | >+9999.0% | +26.9% | -345.2% | +108.2% | >+9999.0% | +45.6% |
OncoSec Medical Incorporated EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2023 | - | -$6.82 M(-15.2%) | -$32.67 M(-8.6%) |
| Oct 2022 | - | -$8.05 M(-2.0%) | -$35.74 M(-4.7%) |
| Jul 2022 | -$37.49 M(-21.2%) | -$8.21 M(-14.3%) | -$37.49 M(-13.8%) |
| Apr 2022 | - | -$9.58 M(-3.2%) | -$43.49 M(+0.3%) |
| Jan 2022 | - | -$9.90 M(+1.0%) | -$43.35 M(-1.8%) |
| Oct 2021 | - | -$9.80 M(-31.0%) | -$44.15 M(-7.2%) |
| Jul 2021 | -$47.56 M(+10.3%) | -$14.21 M(+50.5%) | -$47.56 M(+10.1%) |
| Apr 2021 | - | -$9.44 M(-11.8%) | -$43.20 M(-1.0%) |
| Jan 2021 | - | -$10.70 M(-19.1%) | -$43.65 M(-6.3%) |
| Oct 2020 | - | -$13.22 M(+34.3%) | -$46.58 M(+8.0%) |
| Jul 2020 | -$43.12 M(+42.4%) | -$9.84 M(-0.5%) | -$43.12 M(+5.7%) |
| Apr 2020 | - | -$9.89 M(-27.5%) | -$40.79 M(+8.0%) |
| Jan 2020 | - | -$13.63 M(+39.7%) | -$37.78 M(+16.4%) |
| Oct 2019 | - | -$9.76 M(+30.0%) | -$32.46 M(+7.2%) |
| Jul 2019 | -$30.27 M(-22.7%) | -$7.51 M(+9.2%) | -$30.27 M(-14.0%) |
| Apr 2019 | - | -$6.88 M(-17.2%) | -$35.20 M(-8.3%) |
| Jan 2019 | - | -$8.31 M(+9.7%) | -$38.38 M(+0.1%) |
| Oct 2018 | - | -$7.57 M(-39.1%) | -$38.36 M(+4.5%) |
| Jul 2018 | -$39.14 M(+81.0%) | -$12.44 M(+23.6%) | -$36.71 M(+21.8%) |
| Apr 2018 | - | -$10.06 M(+21.4%) | -$30.14 M(+21.8%) |
| Jan 2018 | - | -$8.29 M(+39.8%) | -$24.76 M(+13.0%) |
| Oct 2017 | - | -$5.93 M(+0.9%) | -$21.90 M(+1.3%) |
| Jul 2017 | -$21.62 M(-19.6%) | -$5.87 M(+25.7%) | -$21.62 M(-3.1%) |
| Apr 2017 | - | -$4.67 M(-14.0%) | -$22.31 M(-6.6%) |
| Jan 2017 | - | -$5.43 M(-3.9%) | -$23.89 M(-6.3%) |
| Oct 2016 | - | -$5.65 M(-13.9%) | -$25.50 M(-5.2%) |
| Jul 2016 | -$26.89 M | -$6.56 M(+5.0%) | -$26.89 M(-0.1%) |
| Apr 2016 | - | -$6.25 M(-11.2%) | -$26.90 M(+1.0%) |
| Jan 2016 | - | -$7.04 M(+0.0%) | -$26.64 M(+10.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2015 | - | -$7.04 M(+7.0%) | -$24.22 M(+14.0%) |
| Jul 2015 | -$21.24 M(+77.8%) | -$6.58 M(+9.9%) | -$21.24 M(+16.7%) |
| Apr 2015 | - | -$5.99 M(+29.6%) | -$18.21 M(+13.5%) |
| Jan 2015 | - | -$4.62 M(+13.7%) | -$16.04 M(+14.4%) |
| Oct 2014 | - | -$4.06 M(+14.6%) | -$14.02 M(+17.3%) |
| Jul 2014 | -$11.95 M(+69.1%) | -$3.54 M(-7.1%) | -$11.95 M(+17.5%) |
| Apr 2014 | - | -$3.82 M(+46.7%) | -$10.17 M(+26.1%) |
| Jan 2014 | - | -$2.60 M(+30.8%) | -$8.06 M(+14.2%) |
| Oct 2013 | - | -$1.99 M(+13.0%) | -$7.06 M(-0.1%) |
| Jul 2013 | -$7.07 M(+237.1%) | -$1.76 M(+3.0%) | -$7.07 M(+2.9%) |
| Apr 2013 | - | -$1.71 M(+7.0%) | -$6.87 M(+16.5%) |
| Jan 2013 | - | -$1.60 M(-20.0%) | -$5.90 M(-14.3%) |
| Oct 2012 | - | -$2.00 M(+27.7%) | -$6.88 M(+228.1%) |
| Jul 2012 | -$2.10 M(-44.2%) | -$1.56 M(+112.2%) | -$2.10 M(-44.6%) |
| Apr 2012 | - | -$737.00 K(-71.4%) | -$3.78 M(+6.8%) |
| Jan 2012 | - | -$2.58 M(-192.6%) | -$3.54 M(+265.3%) |
| Oct 2011 | - | $2.78 M(-185.6%) | -$970.20 K(-74.2%) |
| Jul 2011 | -$3.76 M(>+9900.0%) | -$3.25 M(+555.3%) | -$3.76 M(+629.4%) |
| Apr 2011 | - | -$496.40 K(>+9900.0%) | -$514.90 K(+2283.8%) |
| Jan 2011 | - | -$4300.00(+79.2%) | -$21.60 K(-1.4%) |
| Oct 2010 | - | -$2400.00(-79.7%) | -$21.90 K(-19.2%) |
| Jul 2010 | -$27.20 K(-19.3%) | -$11.80 K(+280.6%) | -$27.10 K(+12.4%) |
| Apr 2010 | - | -$3100.00(-32.6%) | -$24.10 K(-5.9%) |
| Jan 2010 | - | -$4600.00(-39.5%) | -$25.60 K(+18.0%) |
| Oct 2009 | - | -$7600.00(-13.6%) | -$21.70 K(-35.6%) |
| Jul 2009 | -$33.70 K(+368.1%) | -$8800.00(+91.3%) | -$33.70 K(+35.3%) |
| Apr 2009 | - | -$4600.00(+557.1%) | -$24.90 K(+22.7%) |
| Jan 2009 | - | -$700.00(-96.4%) | -$20.30 K(+3.6%) |
| Oct 2008 | - | -$19.60 K | -$19.60 K |
| Jul 2008 | -$7200.00 | - | - |
FAQ
- What is OncoSec Medical Incorporated annual earnings before interest & taxes?
- What is the all time high annual EBIT for OncoSec Medical Incorporated?
- What is OncoSec Medical Incorporated annual EBIT year-on-year change?
- What is OncoSec Medical Incorporated quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for OncoSec Medical Incorporated?
- What is OncoSec Medical Incorporated quarterly EBIT year-on-year change?
- What is OncoSec Medical Incorporated TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for OncoSec Medical Incorporated?
- What is OncoSec Medical Incorporated TTM EBIT year-on-year change?
What is OncoSec Medical Incorporated annual earnings before interest & taxes?
The current annual EBIT of ONCS is -$37.49 M
What is the all time high annual EBIT for OncoSec Medical Incorporated?
OncoSec Medical Incorporated all-time high annual earnings before interest & taxes is -$7200.00
What is OncoSec Medical Incorporated annual EBIT year-on-year change?
Over the past year, ONCS annual earnings before interest & taxes has changed by +$10.07 M (+21.17%)
What is OncoSec Medical Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of ONCS is -$6.82 M
What is the all time high quarterly EBIT for OncoSec Medical Incorporated?
OncoSec Medical Incorporated all-time high quarterly earnings before interest & taxes is $2.78 M
What is OncoSec Medical Incorporated quarterly EBIT year-on-year change?
Over the past year, ONCS quarterly earnings before interest & taxes has changed by +$3.07 M (+31.06%)
What is OncoSec Medical Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of ONCS is -$32.67 M
What is the all time high TTM EBIT for OncoSec Medical Incorporated?
OncoSec Medical Incorporated all-time high TTM earnings before interest & taxes is -$19.60 K
What is OncoSec Medical Incorporated TTM EBIT year-on-year change?
Over the past year, ONCS TTM earnings before interest & taxes has changed by +$10.68 M (+24.64%)